HEADER TRANSFERASE/SIGNALING PROTEIN/INHIBITOR 23-JAN-17 5UKJ TITLE THE CO-STRUCTURE OF N,N-DIMETHYL-4-[(6R)-6-METHYL-5-(1H-PYRROLO[2,3- TITLE 2 B]PYRIDIN-4-YL)-4,5,6,7-TETRAHYDROPYRAZOLO[1,5- A]PYRAZIN-3- TITLE 3 YL]BENZENESULFONAMIDE AND A RATIONALLY DESIGNED PI3K-ALPHA MUTANT TITLE 4 THAT MIMICS ATR COMPND MOL_ID: 1; COMPND 2 MOLECULE: PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC COMPND 3 SUBUNIT ALPHA ISOFORM; COMPND 4 CHAIN: A; COMPND 5 FRAGMENT: UNP RESIDUES; COMPND 6 SYNONYM: PTDINS-3-KINASE SUBUNIT ALPHA,PHOSPHATIDYLINOSITOL 4,5- COMPND 7 BISPHOSPHATE 3-KINASE 110 KDA CATALYTIC SUBUNIT ALPHA,P110ALPHA, COMPND 8 PHOSPHOINOSITIDE-3-KINASE CATALYTIC ALPHA POLYPEPTIDE, COMPND 9 SERINE/THREONINE PROTEIN KINASE PIK3CA; COMPND 10 EC: 2.7.1.153,2.7.11.1; COMPND 11 ENGINEERED: YES; COMPND 12 MUTATION: YES; COMPND 13 OTHER_DETAILS: POINT MUTATIONS TO THE ATP BINDING OF P110 ALPHA COMPND 14 DESIGNED TO TO MIMIC THE LIGAND BINDING PROPERTIES OF ATR; COMPND 15 MOL_ID: 2; COMPND 16 MOLECULE: PHOSPHATIDYLINOSITOL 3-KINASE REGULATORY SUBUNIT ALPHA; COMPND 17 CHAIN: B; COMPND 18 SYNONYM: PTDINS-3-KINASE REGULATORY SUBUNIT ALPHA, COMPND 19 PHOSPHATIDYLINOSITOL 3-KINASE 85 KDA REGULATORY SUBUNIT ALPHA,PTDINS- COMPND 20 3-KINASE REGULATORY SUBUNIT P85-ALPHA; COMPND 21 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PIK3CA; SOURCE 6 EXPRESSION_SYSTEM: UNIDENTIFIED BACULOVIRUS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 10469; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: PIK3R1, GRB1; SOURCE 13 EXPRESSION_SYSTEM: UNIDENTIFIED BACULOVIRUS; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 10469 KEYWDS INHIBITOR, LIPID KINASE, MUTATION, ATR, TRANSFERASE-SIGNALING KEYWDS 2 PROTEIN-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR M.S.KNAPP,R.A.ELLING,M.MAMO REVDAT 2 14-JUN-17 5UKJ 1 JRNL REVDAT 1 10-MAY-17 5UKJ 0 JRNL AUTH Y.LU,M.KNAPP,K.CRAWFORD,R.WARNE,R.ELLING,K.YAN,M.DOYLE, JRNL AUTH 2 G.PARDEE,L.ZHANG,S.MA,M.MAMO,E.ORNELAS,Y.PAN,D.BUSSIERE, JRNL AUTH 3 J.JANSEN,I.ZAROR,A.LAI,P.BARSANTI,J.SIM JRNL TITL RATIONALLY DESIGNED PI3K ALPHA MUTANTS TO MIMIC ATR AND JRNL TITL 2 THEIR USE TO UNDERSTAND BINDING SPECIFICITY OF ATR JRNL TITL 3 INHIBITORS. JRNL REF J. MOL. BIOL. V. 429 1684 2017 JRNL REFN ESSN 1089-8638 JRNL PMID 28433539 JRNL DOI 10.1016/J.JMB.2017.04.006 REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT 2.11.6 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SMART,VONRHEIN,WOMACK, REMARK 3 : MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.01 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 93.8 REMARK 3 NUMBER OF REFLECTIONS : 35197 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.190 REMARK 3 R VALUE (WORKING SET) : 0.187 REMARK 3 FREE R VALUE : 0.252 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.860 REMARK 3 FREE R VALUE TEST SET COUNT : 1712 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 18 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.88 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.31 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 3013 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2410 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2870 REMARK 3 BIN R VALUE (WORKING SET) : 0.2360 REMARK 3 BIN FREE R VALUE : 0.3450 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.75 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 143 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 10181 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 31 REMARK 3 SOLVENT ATOMS : 212 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 73.21 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 63.17 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 9.71980 REMARK 3 B22 (A**2) : -6.43240 REMARK 3 B33 (A**2) : -3.28750 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.340 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.386 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.941 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.909 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 10432 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 14126 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 3681 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 289 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 1509 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 10432 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 1350 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 11895 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.12 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.63 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 19.00 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): 9.6282 -27.5081 -28.4768 REMARK 3 T TENSOR REMARK 3 T11: 0.0000 T22: 0.0000 REMARK 3 T33: 0.0000 T12: 0.0000 REMARK 3 T13: 0.0000 T23: 0.0000 REMARK 3 L TENSOR REMARK 3 L11: 0.0000 L22: 0.0000 REMARK 3 L33: 0.0000 L12: 0.0000 REMARK 3 L13: 0.0000 L23: 0.0000 REMARK 3 S TENSOR REMARK 3 S11: 0.0000 S12: 0.0000 S13: 0.0000 REMARK 3 S21: 0.0000 S22: 0.0000 S23: 0.0000 REMARK 3 S31: 0.0000 S32: 0.0000 S33: 0.0000 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|* } REMARK 3 ORIGIN FOR THE GROUP (A): 15.4093 -15.6628 -49.4017 REMARK 3 T TENSOR REMARK 3 T11: 0.0000 T22: 0.0000 REMARK 3 T33: 0.0000 T12: 0.0000 REMARK 3 T13: 0.0000 T23: 0.0000 REMARK 3 L TENSOR REMARK 3 L11: 0.0000 L22: 0.0000 REMARK 3 L33: 0.0000 L12: 0.0000 REMARK 3 L13: 0.0000 L23: 0.0000 REMARK 3 S TENSOR REMARK 3 S11: 0.0000 S12: 0.0000 S13: 0.0000 REMARK 3 S21: 0.0000 S22: 0.0000 S23: 0.0000 REMARK 3 S31: 0.0000 S32: 0.0000 S33: 0.0000 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5UKJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 26-JAN-17. REMARK 100 THE DEPOSITION ID IS D_1000226010. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 27-FEB-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.5.28 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 38867 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.710 REMARK 200 RESOLUTION RANGE LOW (A) : 47.010 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.4 REMARK 200 DATA REDUNDANCY : 6.100 REMARK 200 R MERGE (I) : 0.08600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.71 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.86 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.7 REMARK 200 DATA REDUNDANCY IN SHELL : 6.30 REMARK 200 R MERGE FOR SHELL (I) : 0.75200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: IN-HOUSE REMARK 200 REMARK 200 REMARK: LONG RECTANGULAR RODS REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.13 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.33 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 3 UL OF PROTEIN WAS MIXED WITH 5 UL OF REMARK 280 WELL SOLUTION CONTAINING 12% PEG 3350 AND 120 MM POTASSIUM REMARK 280 THIOCYANATE, PH 7.2, VAPOR DIFFUSION, HANGING DROP,, TEMPERATURE REMARK 280 303.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 50.09300 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 68.07400 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 54.71600 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 68.07400 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 50.09300 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 54.71600 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6070 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 54380 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -15.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 THR A 229 REMARK 465 ARG A 230 REMARK 465 SER A 231 REMARK 465 LYS A 232 REMARK 465 LYS A 233 REMARK 465 LEU A 234 REMARK 465 SER A 235 REMARK 465 SER A 236 REMARK 465 ALA A 314 REMARK 465 THR A 315 REMARK 465 PRO A 316 REMARK 465 TYR A 317 REMARK 465 MET A 318 REMARK 465 ASN A 319 REMARK 465 GLY A 320 REMARK 465 GLU A 321 REMARK 465 THR A 322 REMARK 465 GLU A 503 REMARK 465 ALA A 504 REMARK 465 GLY A 505 REMARK 465 PHE A 506 REMARK 465 SER A 507 REMARK 465 TYR A 508 REMARK 465 SER A 509 REMARK 465 HIS A 510 REMARK 465 ALA A 511 REMARK 465 GLY A 512 REMARK 465 LEU A 513 REMARK 465 SER A 514 REMARK 465 ASN A 515 REMARK 465 ARG A 516 REMARK 465 LEU A 517 REMARK 465 ALA A 518 REMARK 465 ARG A 519 REMARK 465 ASP A 520 REMARK 465 ASN A 521 REMARK 465 GLY A 864 REMARK 465 GLY A 865 REMARK 465 LEU A 866 REMARK 465 LYS A 867 REMARK 465 GLY A 868 REMARK 465 ALA A 869 REMARK 465 LEU A 870 REMARK 465 LYS A 1054 REMARK 465 MET A 1055 REMARK 465 ASP A 1056 REMARK 465 TRP A 1057 REMARK 465 ILE A 1058 REMARK 465 PHE A 1059 REMARK 465 HIS A 1060 REMARK 465 THR A 1061 REMARK 465 ILE A 1062 REMARK 465 LYS A 1063 REMARK 465 GLN A 1064 REMARK 465 HIS A 1065 REMARK 465 ALA A 1066 REMARK 465 LEU A 1067 REMARK 465 ASN A 1068 REMARK 465 HIS A 1069 REMARK 465 HIS A 1070 REMARK 465 HIS A 1071 REMARK 465 HIS A 1072 REMARK 465 HIS A 1073 REMARK 465 HIS A 1074 REMARK 465 MET B 301 REMARK 465 HIS B 302 REMARK 465 ASN B 303 REMARK 465 LEU B 304 REMARK 465 GLN B 305 REMARK 465 TYR B 306 REMARK 465 LEU B 307 REMARK 465 PRO B 308 REMARK 465 PRO B 309 REMARK 465 LYS B 310 REMARK 465 PRO B 311 REMARK 465 PRO B 312 REMARK 465 LYS B 313 REMARK 465 PRO B 314 REMARK 465 THR B 315 REMARK 465 THR B 316 REMARK 465 VAL B 317 REMARK 465 ALA B 318 REMARK 465 ASN B 319 REMARK 465 ASN B 320 REMARK 465 GLY B 321 REMARK 465 MET B 322 REMARK 465 ASN B 323 REMARK 465 ASN B 324 REMARK 465 ASN B 325 REMARK 465 MET B 326 REMARK 465 MET B 364 REMARK 465 HIS B 365 REMARK 465 GLY B 366 REMARK 465 PRO B 418 REMARK 465 LYS B 419 REMARK 465 LEU B 420 REMARK 465 GLN B 435 REMARK 465 VAL B 436 REMARK 465 LYS B 592 REMARK 465 LYS B 593 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 109 CG CD OE1 OE2 REMARK 470 MET A 130 CG SD CE REMARK 470 LYS A 132 CG CD CE NZ REMARK 470 ARG A 141 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 149 CG CD OE1 OE2 REMARK 470 LYS A 179 CG CD CE NZ REMARK 470 LYS A 187 CG CD CE NZ REMARK 470 ASN A 201 CG OD1 ND2 REMARK 470 ASP A 203 CG OD1 OD2 REMARK 470 LYS A 204 CG CD CE NZ REMARK 470 LYS A 228 CG CD CE NZ REMARK 470 GLU A 237 CG CD OE1 OE2 REMARK 470 GLN A 238 CG CD OE1 NE2 REMARK 470 LEU A 239 CG CD1 CD2 REMARK 470 LYS A 240 CG CD CE NZ REMARK 470 LEU A 241 CG CD1 CD2 REMARK 470 LEU A 244 CG CD1 CD2 REMARK 470 TYR A 246 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 LYS A 249 CG CD CE NZ REMARK 470 GLN A 296 CG CD OE1 NE2 REMARK 470 SER A 306 OG REMARK 470 THR A 313 OG1 CG2 REMARK 470 ARG A 349 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 365 CG CD OE1 OE2 REMARK 470 LYS A 413 CG CD CE NZ REMARK 470 LYS A 416 CG CD CE NZ REMARK 470 GLU A 494 CG CD OE1 OE2 REMARK 470 GLU A 522 CG CD OE1 OE2 REMARK 470 LEU A 523 CG CD1 CD2 REMARK 470 ARG A 524 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 528 CG CD CE NZ REMARK 470 LYS A 532 CG CD CE NZ REMARK 470 LYS A 573 CG CD CE NZ REMARK 470 LYS A 588 CG CD CE NZ REMARK 470 LYS A 621 CG CD CE NZ REMARK 470 MET A 697 CG SD CE REMARK 470 LYS A 776 CG CD CE NZ REMARK 470 LYS A 863 CG CD CE NZ REMARK 470 GLN A 871 CG CD OE1 NE2 REMARK 470 LYS A 882 CG CD CE NZ REMARK 470 LYS A 884 CG CD CE NZ REMARK 470 LYS A 941 CG CD CE NZ REMARK 470 LYS A 948 CG CD CE NZ REMARK 470 ARG A 949 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 973 CD CE NZ REMARK 470 LYS A 986 CG CD CE NZ REMARK 470 THR A1053 OG1 CG2 REMARK 470 LYS B 363 CG CD CE NZ REMARK 470 LYS B 374 CG CD CE NZ REMARK 470 GLU B 411 CG CD OE1 OE2 REMARK 470 LYS B 423 CG CD CE NZ REMARK 470 GLN B 433 CG CD OE1 NE2 REMARK 470 VAL B 437 CG1 CG2 REMARK 470 LYS B 438 CG CD CE NZ REMARK 470 GLU B 443 CG CD OE1 OE2 REMARK 470 ARG B 465 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 506 CG CD CE NZ REMARK 470 LYS B 511 CG CD CE NZ REMARK 470 LYS B 513 CG CD CE NZ REMARK 470 ARG B 514 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 515 CG CD OE1 OE2 REMARK 470 GLU B 518 CG CD OE1 OE2 REMARK 470 LYS B 519 CG CD CE NZ REMARK 470 TRP B 583 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP B 583 CZ3 CH2 REMARK 470 LYS B 587 CG CD CE NZ REMARK 470 ARG B 590 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 63 -170.29 -69.06 REMARK 500 ASN A 157 47.35 -104.87 REMARK 500 SER A 158 -114.00 40.97 REMARK 500 GLU A 176 104.26 -50.66 REMARK 500 LYS A 264 55.97 -66.07 REMARK 500 ARG A 309 6.47 -65.74 REMARK 500 LEU A 339 -77.56 -78.71 REMARK 500 SER A 481 -0.26 83.22 REMARK 500 ARG A 524 127.17 68.20 REMARK 500 ILE A 561 78.27 -114.22 REMARK 500 GLN A 721 -88.60 -112.46 REMARK 500 LYS A 776 -34.52 127.33 REMARK 500 MET A 789 56.30 -116.16 REMARK 500 LEU A 793 -68.38 -120.40 REMARK 500 PHE A 794 139.62 -172.40 REMARK 500 ASP A 830 48.52 -96.11 REMARK 500 GLN A 861 0.06 -65.72 REMARK 500 CYS A 862 -112.10 -134.87 REMARK 500 ILE A 889 31.58 -94.44 REMARK 500 ASP A 915 122.34 -35.82 REMARK 500 ASP A 933 82.25 58.22 REMARK 500 PHE A 934 59.36 -107.01 REMARK 500 LEU A 938 -154.18 64.37 REMARK 500 ALA A1027 59.88 38.21 REMARK 500 GLN B 329 -20.00 96.55 REMARK 500 ASP B 337 21.92 -76.83 REMARK 500 ALA B 360 157.40 -46.53 REMARK 500 THR B 362 -104.24 -87.75 REMARK 500 ASN B 517 63.69 -104.52 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 3K6 A 1101 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5UK8 RELATED DB: PDB REMARK 900 RELATED ID: 5UL1 RELATED DB: PDB DBREF 5UKJ A 1 1068 UNP P42336 PK3CA_HUMAN 1 1068 DBREF 5UKJ B 301 593 UNP P27986 P85A_HUMAN 1 293 SEQADV 5UKJ LYS A 232 UNP P42336 MET 232 ENGINEERED MUTATION SEQADV 5UKJ LYS A 233 UNP P42336 LEU 233 ENGINEERED MUTATION SEQADV 5UKJ GLU A 770 UNP P42336 ARG 770 ENGINEERED MUTATION SEQADV 5UKJ LYS A 780 UNP P42336 TRP 780 ENGINEERED MUTATION SEQADV 5UKJ ILE A 798 UNP P42336 GLU 798 ENGINEERED MUTATION SEQADV 5UKJ MET A 800 UNP P42336 ILE 800 ENGINEERED MUTATION SEQADV 5UKJ TRP A 850 UNP P42336 VAL 850 ENGINEERED MUTATION SEQADV 5UKJ VAL A 930 UNP P42336 PHE 930 ENGINEERED MUTATION SEQADV 5UKJ HIS A 1069 UNP P42336 EXPRESSION TAG SEQADV 5UKJ HIS A 1070 UNP P42336 EXPRESSION TAG SEQADV 5UKJ HIS A 1071 UNP P42336 EXPRESSION TAG SEQADV 5UKJ HIS A 1072 UNP P42336 EXPRESSION TAG SEQADV 5UKJ HIS A 1073 UNP P42336 EXPRESSION TAG SEQADV 5UKJ HIS A 1074 UNP P42336 EXPRESSION TAG SEQADV 5UKJ TYR B 306 UNP P27986 THR 6 ENGINEERED MUTATION SEQRES 1 A 1074 MET PRO PRO ARG PRO SER SER GLY GLU LEU TRP GLY ILE SEQRES 2 A 1074 HIS LEU MET PRO PRO ARG ILE LEU VAL GLU CYS LEU LEU SEQRES 3 A 1074 PRO ASN GLY MET ILE VAL THR LEU GLU CYS LEU ARG GLU SEQRES 4 A 1074 ALA THR LEU ILE THR ILE LYS HIS GLU LEU PHE LYS GLU SEQRES 5 A 1074 ALA ARG LYS TYR PRO LEU HIS GLN LEU LEU GLN ASP GLU SEQRES 6 A 1074 SER SER TYR ILE PHE VAL SER VAL THR GLN GLU ALA GLU SEQRES 7 A 1074 ARG GLU GLU PHE PHE ASP GLU THR ARG ARG LEU CYS ASP SEQRES 8 A 1074 LEU ARG LEU PHE GLN PRO PHE LEU LYS VAL ILE GLU PRO SEQRES 9 A 1074 VAL GLY ASN ARG GLU GLU LYS ILE LEU ASN ARG GLU ILE SEQRES 10 A 1074 GLY PHE ALA ILE GLY MET PRO VAL CYS GLU PHE ASP MET SEQRES 11 A 1074 VAL LYS ASP PRO GLU VAL GLN ASP PHE ARG ARG ASN ILE SEQRES 12 A 1074 LEU ASN VAL CYS LYS GLU ALA VAL ASP LEU ARG ASP LEU SEQRES 13 A 1074 ASN SER PRO HIS SER ARG ALA MET TYR VAL TYR PRO PRO SEQRES 14 A 1074 ASN VAL GLU SER SER PRO GLU LEU PRO LYS HIS ILE TYR SEQRES 15 A 1074 ASN LYS LEU ASP LYS GLY GLN ILE ILE VAL VAL ILE TRP SEQRES 16 A 1074 VAL ILE VAL SER PRO ASN ASN ASP LYS GLN LYS TYR THR SEQRES 17 A 1074 LEU LYS ILE ASN HIS ASP CYS VAL PRO GLU GLN VAL ILE SEQRES 18 A 1074 ALA GLU ALA ILE ARG LYS LYS THR ARG SER LYS LYS LEU SEQRES 19 A 1074 SER SER GLU GLN LEU LYS LEU CYS VAL LEU GLU TYR GLN SEQRES 20 A 1074 GLY LYS TYR ILE LEU LYS VAL CYS GLY CYS ASP GLU TYR SEQRES 21 A 1074 PHE LEU GLU LYS TYR PRO LEU SER GLN TYR LYS TYR ILE SEQRES 22 A 1074 ARG SER CYS ILE MET LEU GLY ARG MET PRO ASN LEU MET SEQRES 23 A 1074 LEU MET ALA LYS GLU SER LEU TYR SER GLN LEU PRO MET SEQRES 24 A 1074 ASP CYS PHE THR MET PRO SER TYR SER ARG ARG ILE SER SEQRES 25 A 1074 THR ALA THR PRO TYR MET ASN GLY GLU THR SER THR LYS SEQRES 26 A 1074 SER LEU TRP VAL ILE ASN SER ALA LEU ARG ILE LYS ILE SEQRES 27 A 1074 LEU CYS ALA THR TYR VAL ASN VAL ASN ILE ARG ASP ILE SEQRES 28 A 1074 ASP LYS ILE TYR VAL ARG THR GLY ILE TYR HIS GLY GLY SEQRES 29 A 1074 GLU PRO LEU CYS ASP ASN VAL ASN THR GLN ARG VAL PRO SEQRES 30 A 1074 CYS SER ASN PRO ARG TRP ASN GLU TRP LEU ASN TYR ASP SEQRES 31 A 1074 ILE TYR ILE PRO ASP LEU PRO ARG ALA ALA ARG LEU CYS SEQRES 32 A 1074 LEU SER ILE CYS SER VAL LYS GLY ARG LYS GLY ALA LYS SEQRES 33 A 1074 GLU GLU HIS CYS PRO LEU ALA TRP GLY ASN ILE ASN LEU SEQRES 34 A 1074 PHE ASP TYR THR ASP THR LEU VAL SER GLY LYS MET ALA SEQRES 35 A 1074 LEU ASN LEU TRP PRO VAL PRO HIS GLY LEU GLU ASP LEU SEQRES 36 A 1074 LEU ASN PRO ILE GLY VAL THR GLY SER ASN PRO ASN LYS SEQRES 37 A 1074 GLU THR PRO CYS LEU GLU LEU GLU PHE ASP TRP PHE SER SEQRES 38 A 1074 SER VAL VAL LYS PHE PRO ASP MET SER VAL ILE GLU GLU SEQRES 39 A 1074 HIS ALA ASN TRP SER VAL SER ARG GLU ALA GLY PHE SER SEQRES 40 A 1074 TYR SER HIS ALA GLY LEU SER ASN ARG LEU ALA ARG ASP SEQRES 41 A 1074 ASN GLU LEU ARG GLU ASN ASP LYS GLU GLN LEU LYS ALA SEQRES 42 A 1074 ILE SER THR ARG ASP PRO LEU SER GLU ILE THR GLU GLN SEQRES 43 A 1074 GLU LYS ASP PHE LEU TRP SER HIS ARG HIS TYR CYS VAL SEQRES 44 A 1074 THR ILE PRO GLU ILE LEU PRO LYS LEU LEU LEU SER VAL SEQRES 45 A 1074 LYS TRP ASN SER ARG ASP GLU VAL ALA GLN MET TYR CYS SEQRES 46 A 1074 LEU VAL LYS ASP TRP PRO PRO ILE LYS PRO GLU GLN ALA SEQRES 47 A 1074 MET GLU LEU LEU ASP CYS ASN TYR PRO ASP PRO MET VAL SEQRES 48 A 1074 ARG GLY PHE ALA VAL ARG CYS LEU GLU LYS TYR LEU THR SEQRES 49 A 1074 ASP ASP LYS LEU SER GLN TYR LEU ILE GLN LEU VAL GLN SEQRES 50 A 1074 VAL LEU LYS TYR GLU GLN TYR LEU ASP ASN LEU LEU VAL SEQRES 51 A 1074 ARG PHE LEU LEU LYS LYS ALA LEU THR ASN GLN ARG ILE SEQRES 52 A 1074 GLY HIS PHE PHE PHE TRP HIS LEU LYS SER GLU MET HIS SEQRES 53 A 1074 ASN LYS THR VAL SER GLN ARG PHE GLY LEU LEU LEU GLU SEQRES 54 A 1074 SER TYR CYS ARG ALA CYS GLY MET TYR LEU LYS HIS LEU SEQRES 55 A 1074 ASN ARG GLN VAL GLU ALA MET GLU LYS LEU ILE ASN LEU SEQRES 56 A 1074 THR ASP ILE LEU LYS GLN GLU LYS LYS ASP GLU THR GLN SEQRES 57 A 1074 LYS VAL GLN MET LYS PHE LEU VAL GLU GLN MET ARG ARG SEQRES 58 A 1074 PRO ASP PHE MET ASP ALA LEU GLN GLY PHE LEU SER PRO SEQRES 59 A 1074 LEU ASN PRO ALA HIS GLN LEU GLY ASN LEU ARG LEU GLU SEQRES 60 A 1074 GLU CYS GLU ILE MET SER SER ALA LYS ARG PRO LEU LYS SEQRES 61 A 1074 LEU ASN TRP GLU ASN PRO ASP ILE MET SER GLU LEU LEU SEQRES 62 A 1074 PHE GLN ASN ASN ILE ILE MET PHE LYS ASN GLY ASP ASP SEQRES 63 A 1074 LEU ARG GLN ASP MET LEU THR LEU GLN ILE ILE ARG ILE SEQRES 64 A 1074 MET GLU ASN ILE TRP GLN ASN GLN GLY LEU ASP LEU ARG SEQRES 65 A 1074 MET LEU PRO TYR GLY CYS LEU SER ILE GLY ASP CYS VAL SEQRES 66 A 1074 GLY LEU ILE GLU TRP VAL ARG ASN SER HIS THR ILE MET SEQRES 67 A 1074 GLN ILE GLN CYS LYS GLY GLY LEU LYS GLY ALA LEU GLN SEQRES 68 A 1074 PHE ASN SER HIS THR LEU HIS GLN TRP LEU LYS ASP LYS SEQRES 69 A 1074 ASN LYS GLY GLU ILE TYR ASP ALA ALA ILE ASP LEU PHE SEQRES 70 A 1074 THR ARG SER CYS ALA GLY TYR CYS VAL ALA THR PHE ILE SEQRES 71 A 1074 LEU GLY ILE GLY ASP ARG HIS ASN SER ASN ILE MET VAL SEQRES 72 A 1074 LYS ASP ASP GLY GLN LEU VAL HIS ILE ASP PHE GLY HIS SEQRES 73 A 1074 PHE LEU ASP HIS LYS LYS LYS LYS PHE GLY TYR LYS ARG SEQRES 74 A 1074 GLU ARG VAL PRO PHE VAL LEU THR GLN ASP PHE LEU ILE SEQRES 75 A 1074 VAL ILE SER LYS GLY ALA GLN GLU CYS THR LYS THR ARG SEQRES 76 A 1074 GLU PHE GLU ARG PHE GLN GLU MET CYS TYR LYS ALA TYR SEQRES 77 A 1074 LEU ALA ILE ARG GLN HIS ALA ASN LEU PHE ILE ASN LEU SEQRES 78 A 1074 PHE SER MET MET LEU GLY SER GLY MET PRO GLU LEU GLN SEQRES 79 A 1074 SER PHE ASP ASP ILE ALA TYR ILE ARG LYS THR LEU ALA SEQRES 80 A 1074 LEU ASP LYS THR GLU GLN GLU ALA LEU GLU TYR PHE MET SEQRES 81 A 1074 LYS GLN MET ASN ASP ALA HIS HIS GLY GLY TRP THR THR SEQRES 82 A 1074 LYS MET ASP TRP ILE PHE HIS THR ILE LYS GLN HIS ALA SEQRES 83 A 1074 LEU ASN HIS HIS HIS HIS HIS HIS SEQRES 1 B 293 MET HIS ASN LEU GLN TYR LEU PRO PRO LYS PRO PRO LYS SEQRES 2 B 293 PRO THR THR VAL ALA ASN ASN GLY MET ASN ASN ASN MET SEQRES 3 B 293 SER LEU GLN ASP ALA GLU TRP TYR TRP GLY ASP ILE SER SEQRES 4 B 293 ARG GLU GLU VAL ASN GLU LYS LEU ARG ASP THR ALA ASP SEQRES 5 B 293 GLY THR PHE LEU VAL ARG ASP ALA SER THR LYS MET HIS SEQRES 6 B 293 GLY ASP TYR THR LEU THR LEU ARG LYS GLY GLY ASN ASN SEQRES 7 B 293 LYS LEU ILE LYS ILE PHE HIS ARG ASP GLY LYS TYR GLY SEQRES 8 B 293 PHE SER ASP PRO LEU THR PHE SER SER VAL VAL GLU LEU SEQRES 9 B 293 ILE ASN HIS TYR ARG ASN GLU SER LEU ALA GLN TYR ASN SEQRES 10 B 293 PRO LYS LEU ASP VAL LYS LEU LEU TYR PRO VAL SER LYS SEQRES 11 B 293 TYR GLN GLN ASP GLN VAL VAL LYS GLU ASP ASN ILE GLU SEQRES 12 B 293 ALA VAL GLY LYS LYS LEU HIS GLU TYR ASN THR GLN PHE SEQRES 13 B 293 GLN GLU LYS SER ARG GLU TYR ASP ARG LEU TYR GLU GLU SEQRES 14 B 293 TYR THR ARG THR SER GLN GLU ILE GLN MET LYS ARG THR SEQRES 15 B 293 ALA ILE GLU ALA PHE ASN GLU THR ILE LYS ILE PHE GLU SEQRES 16 B 293 GLU GLN CYS GLN THR GLN GLU ARG TYR SER LYS GLU TYR SEQRES 17 B 293 ILE GLU LYS PHE LYS ARG GLU GLY ASN GLU LYS GLU ILE SEQRES 18 B 293 GLN ARG ILE MET HIS ASN TYR ASP LYS LEU LYS SER ARG SEQRES 19 B 293 ILE SER GLU ILE ILE ASP SER ARG ARG ARG LEU GLU GLU SEQRES 20 B 293 ASP LEU LYS LYS GLN ALA ALA GLU TYR ARG GLU ILE ASP SEQRES 21 B 293 LYS ARG MET ASN SER ILE LYS PRO ASP LEU ILE GLN LEU SEQRES 22 B 293 ARG LYS THR ARG ASP GLN TYR LEU MET TRP LEU THR GLN SEQRES 23 B 293 LYS GLY VAL ARG GLN LYS LYS HET 3K6 A1101 31 HETNAM 3K6 N,N-DIMETHYL-4-[(6R)-6-METHYL-5-(1H-PYRROLO[2,3- HETNAM 2 3K6 B]PYRIDIN-4-YL)-4,5,6,7-TETRAHYDROPYRAZOLO[1,5- HETNAM 3 3K6 A]PYRAZIN-3-YL]BENZENESULFONAMIDE FORMUL 3 3K6 C22 H24 N6 O2 S FORMUL 4 HOH *212(H2 O) HELIX 1 AA1 THR A 41 ARG A 54 1 14 HELIX 2 AA2 LEU A 58 LEU A 62 5 5 HELIX 3 AA3 ASP A 64 TYR A 68 5 5 HELIX 4 AA4 ARG A 88 LEU A 92 5 5 HELIX 5 AA5 ASN A 107 GLY A 122 1 16 HELIX 6 AA6 VAL A 125 VAL A 131 1 7 HELIX 7 AA7 ASP A 133 ILE A 143 1 11 HELIX 8 AA8 ILE A 143 ASP A 155 1 13 HELIX 9 AA9 ASN A 157 TYR A 167 1 11 HELIX 10 AB1 PRO A 178 ASN A 183 1 6 HELIX 11 AB2 VAL A 216 LYS A 228 1 13 HELIX 12 AB3 LEU A 239 GLN A 247 1 9 HELIX 13 AB4 PRO A 266 GLN A 269 5 4 HELIX 14 AB5 TYR A 270 LEU A 279 1 10 HELIX 15 AB6 LYS A 290 SER A 295 1 6 HELIX 16 AB7 PRO A 394 LEU A 396 5 3 HELIX 17 AB8 ASP A 488 SER A 501 1 14 HELIX 18 AB9 ARG A 524 THR A 536 1 13 HELIX 19 AC1 THR A 544 HIS A 554 1 11 HELIX 20 AC2 TYR A 557 GLU A 563 5 7 HELIX 21 AC3 ILE A 564 LEU A 570 1 7 HELIX 22 AC4 SER A 576 ASP A 589 1 14 HELIX 23 AC5 LYS A 594 MET A 599 1 6 HELIX 24 AC6 GLU A 600 ASP A 603 5 4 HELIX 25 AC7 ASP A 608 LEU A 623 1 16 HELIX 26 AC8 THR A 624 TYR A 631 1 8 HELIX 27 AC9 TYR A 631 VAL A 638 1 8 HELIX 28 AD1 LEU A 639 TYR A 641 5 3 HELIX 29 AD2 ASN A 647 ASN A 660 1 14 HELIX 30 AD3 ASN A 660 SER A 673 1 14 HELIX 31 AD4 VAL A 680 CYS A 695 1 16 HELIX 32 AD5 MET A 697 GLN A 721 1 25 HELIX 33 AD6 THR A 727 MET A 739 1 13 HELIX 34 AD7 ARG A 741 GLN A 749 1 9 HELIX 35 AD8 ARG A 765 CYS A 769 5 5 HELIX 36 AD9 MET A 789 LEU A 793 5 5 HELIX 37 AE1 LEU A 807 GLN A 827 1 21 HELIX 38 AE2 ILE A 857 GLN A 861 1 5 HELIX 39 AE3 HIS A 875 ASN A 885 1 11 HELIX 40 AE4 LYS A 886 GLU A 888 5 3 HELIX 41 AE5 ILE A 889 GLY A 912 1 24 HELIX 42 AE6 THR A 957 SER A 965 1 9 HELIX 43 AE7 THR A 974 HIS A 994 1 21 HELIX 44 AE8 HIS A 994 MET A 1004 1 11 HELIX 45 AE9 SER A 1015 LEU A 1026 1 12 HELIX 46 AF1 THR A 1031 HIS A 1048 1 18 HELIX 47 AF2 SER B 339 ARG B 348 1 10 HELIX 48 AF3 SER B 400 GLU B 411 1 12 HELIX 49 AF4 ASN B 441 GLU B 515 1 75 HELIX 50 AF5 ASN B 517 GLY B 588 1 72 SHEET 1 AA1 5 ILE A 31 LEU A 37 0 SHEET 2 AA1 5 ARG A 19 LEU A 25 -1 N ILE A 20 O CYS A 36 SHEET 3 AA1 5 PHE A 98 ILE A 102 1 O LEU A 99 N LEU A 25 SHEET 4 AA1 5 ILE A 69 VAL A 73 -1 N ILE A 69 O ILE A 102 SHEET 5 AA1 5 ARG A 79 PHE A 82 -1 O PHE A 82 N PHE A 70 SHEET 1 AA2 5 ASP A 203 ASN A 212 0 SHEET 2 AA2 5 GLN A 189 VAL A 198 -1 N VAL A 198 O ASP A 203 SHEET 3 AA2 5 ASN A 284 ALA A 289 1 O LEU A 285 N TRP A 195 SHEET 4 AA2 5 TYR A 250 VAL A 254 -1 N ILE A 251 O MET A 288 SHEET 5 AA2 5 TYR A 260 PHE A 261 -1 O PHE A 261 N LEU A 252 SHEET 1 AA3 2 THR A 324 SER A 326 0 SHEET 2 AA3 2 VAL A 483 LYS A 485 1 O LYS A 485 N LYS A 325 SHEET 1 AA4 4 ARG A 382 TYR A 392 0 SHEET 2 AA4 4 ALA A 333 ALA A 341 -1 N ILE A 336 O LEU A 387 SHEET 3 AA4 4 CYS A 472 PHE A 477 -1 O GLU A 474 N CYS A 340 SHEET 4 AA4 4 GLY A 439 ASN A 444 -1 N LEU A 443 O LEU A 473 SHEET 1 AA5 3 GLU A 365 PRO A 366 0 SHEET 2 AA5 3 LYS A 353 HIS A 362 -1 N HIS A 362 O GLU A 365 SHEET 3 AA5 3 VAL A 371 ASN A 372 -1 O VAL A 371 N THR A 358 SHEET 1 AA6 5 GLU A 365 PRO A 366 0 SHEET 2 AA6 5 LYS A 353 HIS A 362 -1 N HIS A 362 O GLU A 365 SHEET 3 AA6 5 ARG A 401 LYS A 410 -1 O CYS A 403 N GLY A 359 SHEET 4 AA6 5 GLU A 418 ASN A 428 -1 O LEU A 422 N ILE A 406 SHEET 5 AA6 5 TRP A 446 PRO A 447 -1 O TRP A 446 N TRP A 424 SHEET 1 AA7 2 PHE A 751 SER A 753 0 SHEET 2 AA7 2 ASN A 756 LEU A 761 -1 O LEU A 761 N PHE A 751 SHEET 1 AA8 5 GLU A 770 ILE A 771 0 SHEET 2 AA8 5 LEU A 779 GLU A 784 -1 O LYS A 780 N GLU A 770 SHEET 3 AA8 5 ASN A 796 ASN A 803 -1 O PHE A 801 N LEU A 779 SHEET 4 AA8 5 VAL A 845 GLU A 849 -1 O ILE A 848 N MET A 800 SHEET 5 AA8 5 CYS A 838 GLY A 842 -1 N LEU A 839 O LEU A 847 SHEET 1 AA9 3 SER A 854 THR A 856 0 SHEET 2 AA9 3 ILE A 921 LYS A 924 -1 O VAL A 923 N HIS A 855 SHEET 3 AA9 3 LEU A 929 HIS A 931 -1 O VAL A 930 N MET A 922 SHEET 1 AB1 5 LYS B 389 GLY B 391 0 SHEET 2 AB1 5 ASN B 377 ARG B 386 -1 N PHE B 384 O GLY B 391 SHEET 3 AB1 5 TYR B 368 LYS B 374 -1 N LEU B 370 O ILE B 381 SHEET 4 AB1 5 THR B 354 ASP B 359 -1 N LEU B 356 O THR B 371 SHEET 5 AB1 5 TYR B 426 PRO B 427 1 O TYR B 426 N PHE B 355 CISPEP 1 ASP B 394 PRO B 395 0 7.96 SITE 1 AC1 14 ILE A 311 MET A 800 LYS A 802 ASP A 810 SITE 2 AC1 14 TYR A 836 GLU A 849 TRP A 850 VAL A 851 SITE 3 AC1 14 SER A 854 HIS A 855 THR A 856 GLN A 859 SITE 4 AC1 14 MET A 922 ASP A 933 CRYST1 100.186 109.432 136.148 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009981 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009138 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007345 0.00000 MASTER 486 0 1 50 39 0 4 6 0 0 0 106 END